RHYTHM PHARMACEUTICALS INC (RYTM) Stock Analyst Earnings Estimates
NASDAQ:RYTM - Nasdaq - US76243J1051 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.15M | 23.64M 650.48% | 77.428M 227.53% | 129.49M 67.24% | 188.26M 45.39% | 329.68M 75.12% | 638.38M 93.64% | 1.005B 57.43% | 1.41B 40.30% | 1.721B 22.06% | 1.459B -15.22% | 1.234B -15.42% | |
| EBITDA YoY % growth | -168.9M -24.29% | -177.49M -5.09% | -182.599M -2.88% | -263.861M -44.50% | -169.245M 35.86% | -80.788M 52.27% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -170.06M -24.51% | -179.16M -5.35% | -184.357M -2.90% | -272.085M -47.59% | -159.733M 41.29% | -64.193M 59.81% | 210.26M 427.54% | 513.33M 144.14% | 870.06M 69.49% | 1.108B 27.35% | 941.36M -15.04% | 734.45M -21.98% | |
| Operating Margin | -5,398.73% | -757.87% | -238.10% | -210.12% | -84.85% | -19.47% | 32.94% | 51.08% | 61.71% | 64.38% | 64.52% | 59.52% | |
| EPS YoY % growth | -3.41 -11.80% | -3.48 -2.05% | -3.20 8.05% | -4.41 -37.76% | -2.63 40.36% | -1.05 59.96% | 2.41 328.65% | 6.22 158.33% | 9.72 56.23% | 12.36 27.19% | 5.95 -51.88% | -1.09 -118.35% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.73 -3.65% | -0.73 69.06% | -0.68 1.45% | -0.68 7.24% | -0.63 12.86% | -0.57 22.27% | -0.51 25.45% | -0.50 26.49% | -0.44 29.66% | 0.18 132.49% | 0.34 166.40% | 0.67 235.25% |
| Revenue Q2Q % growth | 39.254M 61.98% | 40.626M 56.45% | 44.524M 53.12% | 48.298M 45.25% | 53.206M 35.54% | 55.59M 36.83% | 68.34M 53.49% | 81.6M 68.95% | 106.59M 100.33% | 107.1M 92.66% | 122.4M 79.10% | 135.66M 66.25% |
| EBITDA Q2Q % growth | -38.923M 1.48% | -39.821M 71.45% | -41.361M 76.97% | -43.238M -1.25% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -42.523M -3.05% | -41.114M 70.61% | -41.014M 77.26% | -39.574M 9.82% | -34.094M 19.82% | -21.828M 46.91% | -14.892M 63.69% | 2.04M 105.15% | 14.28M 141.88% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.73 3.95% | -0.82 | 0.09 | 11.07% |
| Q2 2024 Q2Q % growth | -0.69 15.85% | -0.73 | 0.04 | 5.17% |
| Q1 2024 Q2Q % growth | -2.35 -155.43% | -2.21 | -0.14 | -6.55% |
| Q4 2023 Q2Q % growth | -0.70 6.67% | -0.71 | 0.01 | 1.68% |
| Q3 2023 Q2Q % growth | -0.76 3.80% | -0.75 | -0.01 | -0.77% |
| Q2 2023 Q2Q % growth | -0.82 7.87% | -0.81 | -0.01 | -1.14% |
| Q1 2023 Q2Q % growth | -0.92 12.38% | -0.92 | 0.00 | 0.28% |
| Q4 2022 Q2Q % growth | -0.75 11.76% | -0.83 | 0.08 | 9.14% |
| Q3 2022 Q2Q % growth | -0.79 -12.86% | -1.02 | 0.23 | 22.60% |
| Q2 2022 Q2Q % growth | -0.89 -27.14% | -0.97 | 0.08 | 7.96% |
| Q1 2022 Q2Q % growth | -1.05 9.48% | -1.03 | -0.02 | -1.53% |
| Q4 2021 Q2Q % growth | -0.85 -7.59% | -0.93 | 0.08 | 8.71% |
| Q3 2021 Q2Q % growth | -0.70 9.09% | -0.82 | 0.12 | 14.92% |
| Q2 2021 Q2Q % growth | -0.70 1.41% | -0.70 | 0.00 | -0.50% |
| Q1 2021 Q2Q % growth | -1.16 -48.72% | 0.30 | -1.46 | -484.53% |
| Q4 2020 Q2Q % growth | -0.79 -1.28% | -0.82 | 0.03 | 3.19% |
| Q3 2020 Q2Q % growth | -0.77 25.96% | -0.82 | 0.05 | 5.64% |
| Q2 2020 Q2Q % growth | -0.71 42.74% | -0.85 | 0.14 | 16.53% |
| Q1 2020 Q2Q % growth | -0.78 7.14% | -0.86 | 0.08 | 9.13% |
| Q4 2019 Q2Q % growth | -0.78 | -0.91 | 0.13 | 14.33% |
| Q3 2019 Q2Q % growth | -1.04 | -1.09 | 0.05 | 4.84% |
| Q2 2019 Q2Q % growth | -1.24 | -0.89 | -0.35 | -38.71% |
| Q1 2019 Q2Q % growth | -0.84 | -0.77 | -0.07 | -8.47% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 33.251M 47.76% | 33.167M | 84K | 0.25% |
| Q2 2024 Q2Q % growth | 29.078M 51.28% | 29.365M | -287K | -0.98% |
| Q1 2024 Q2Q % growth | 25.967M 126.41% | 27.434M | -1.467M | -5.35% |
| Q4 2023 Q2Q % growth | 24.234M 175.70% | 25.888M | -1.654M | -6.39% |
| Q3 2023 Q2Q % growth | 22.504M 425.79% | 22.622M | -118K | -0.52% |
| Q2 2023 Q2Q % growth | 19.221M 111.92% | 15.329M | 3.892M | 25.39% |
| Q1 2023 Q2Q % growth | 11.469M 664.60% | 12.361M | -892K | -7.22% |
| Q4 2022 Q2Q % growth | 8.79M 382.97% | 7.169M | 1.621M | 22.61% |
| Q3 2022 Q2Q % growth | 4.28M 315.53% | 4.857M | -577K | -11.88% |
| Q2 2022 Q2Q % growth | 9.07M 3,259.26% | 2.635M | 6.435M | 244.21% |
| Q1 2022 Q2Q % growth | 1.5M 3,650.00% | 2.347M | -847K | -36.09% |
| Q4 2021 Q2Q % growth | 1.82M | 1.737M | 83K | 4.78% |
| Q3 2021 Q2Q % growth | 1.03M | 952.884K | 77.116K | 8.09% |
| Q2 2021 Q2Q % growth | 270K | 470.424K | -200.424K | -42.60% |
| Q1 2021 Q2Q % growth | 40K | 61.019M | -60.979M | -99.93% |
| Q3 2020 Q2Q % growth | 339.997K | -339.997K | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 4.91% | 4.91% | 0.62% | 2% |
| Revenue | 7.12% | 7.12% | 0.75% | 2.01% |